» Articles » PMID: 38846838

Insights into Calcific Aortic Valve Stenosis: a Comprehensive Overview of the Disease and Advancing Treatment Strategies

Overview
Publisher Wolters Kluwer
Specialty Medical Education
Date 2024 Jun 7
PMID 38846838
Authors
Affiliations
Soon will be listed here.
Abstract

Aortic valve stenosis is a disease characterized by thickening and narrowing of the aortic valve (AV), most commonly due to calcification, which leads to left ventricular outflow obstruction called calcific aortic valve disease (CAVD). CAVD presents as a progressive clinical syndrome with cardiorespiratory symptoms, often with rapid deterioration. The modern-day pathophysiology of CAVD involves a complex interplay of genetic factors, chronic inflammation, lipid deposition, and valve calcification, with early CAVD stages resembling atherosclerosis. Various imaging modalities have been used to evaluate CAVD, with a recent trend of using advanced imaging to measure numerous AV parameters, such as peak jet velocity. Significant improvements in mortality have been achieved with transcatheter AV repair, but numerous therapeutics and modalities are being researched to delay the progression of CAVD. This article aims to provide a comprehensive review of CAVD, explore recent developments, and provide insights into future treatments with various novel modalities.

Citing Articles

Transcatheter Aortic Valve Implantation in Patients with Previous Mitral Valve Surgery-Review.

Olasinska-Wisniewska A, Misterski M, Grygier M, Konstanty-Kalandyk J, Urbanowicz T, Lesiak M J Clin Med. 2025; 14(3).

PMID: 39941404 PMC: 11818685. DOI: 10.3390/jcm14030735.


Aortic Valve Calcium Score: Applications in Clinical Practice and Scientific Research-A Narrative Review.

Gac P, Jaworski A, Grajnert F, Kicman K, Trejtowicz-Sutor A, Witkowski K J Clin Med. 2024; 13(14).

PMID: 39064103 PMC: 11277735. DOI: 10.3390/jcm13144064.

References
1.
Calle-Muller C, Rabbani B, Khan A, Guerrero M . Recurrent ventricular tachycardia from severe aortic stenosis improves after percutaneous aortic balloon valvuloplasty and transcatheter aortic valve replacement. J Cardiol Cases. 2018; 9(6):236-238. PMC: 6278675. DOI: 10.1016/j.jccase.2014.03.005. View

2.
Goyal A, Changez M, Tariq M, Mushtaq F, Shamim U, Sohail A . Efficacy and outcomes of Bempedoic acid versus placebo in patients with statin-intolerance: A pilot systematic review and meta-analysis of randomized controlled trials. Curr Probl Cardiol. 2023; 49(2):102236. DOI: 10.1016/j.cpcardiol.2023.102236. View

3.
Gollmann-Tepekoylu C, Graber M, Hirsch J, Mair S, Naschberger A, Polzl L . Toll-Like Receptor 3 Mediates Aortic Stenosis Through a Conserved Mechanism of Calcification. Circulation. 2023; 147(20):1518-1533. PMC: 10192061. DOI: 10.1161/CIRCULATIONAHA.122.063481. View

4.
Bugnicourt J, Bonnaire B, Lepage L, Garcia P, Lefranc M, Godefroy O . [Stroke due to spontaneous calcified cerebral embolus as presenting feature of calcified aortic stenosis]. J Mal Vasc. 2008; 33(2):106-9. DOI: 10.1016/j.jmv.2008.02.004. View

5.
Lindman B, Sukul D, Dweck M, Madhavan M, Arsenault B, Coylewright M . Evaluating Medical Therapy for Calcific Aortic Stenosis: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021; 78(23):2354-2376. PMC: 8647810. DOI: 10.1016/j.jacc.2021.09.1367. View